UBS Reaffirms Their Buy Rating on CME Group (CME)
Stay Ahead of the Market:
Discover outperforming stocks and invest smarter with Top Smart Score Stocks.
Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener.
Kramm covers the Financial sector, focusing on stocks such as CME Group, Nasdaq, and Intercontinental Exchange. According to TipRanks, Kramm has an average return of 10.5% and a 62.15% success rate on recommended stocks.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for CME Group with a $273.15 average price target, implying a 2.57% upside from current levels. In a report released on April 24, Piper Sandler also maintained a Buy rating on the stock with a $283.00 price target.
CME market cap is currently $94.88B and has a P/E ratio of 26.47.
Based on the recent corporate insider activity of 96 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CME in relation to earlier this year. Last month, William Shepard, a Director at CME bought 11.00 shares for a total of $2,888.82.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
UBS and Truist Financial Maintain ‘Buy' Ratings on The Procter & Gamble Company (PG); Barclays Reiterates ‘Hold' Rating
The Procter & Gamble Company (NYSE:PG) is included in our list of the . Copyright: jetcityimage / 123RF Stock Photo Following the company's fourth-quarter results, UBS reiterated its 'Buy' rating with a $180 price target on July 30, 2025. The Procter & Gamble Company (NYSE:PG)'s underlying sales growth guidance of 2.5%-4.5%, alongside EPS growth of 5%-7%, fueled the analyst's optimism. This update comes despite a post-earnings pullback driven by one-time pressures, which include a Mexico joint venture exit and normalized incentive compensation. Looking ahead, the analyst keeps its bullish stance due to improving U.S. local case volumes and long-term growth potential through sales force expansion, AI 360 CRM, pricing agility, and Perks 2.0. Meanwhile, on the same day, Truist Financial also maintained its 'Buy' rating on The Procter & Gamble Company (NYSE:PG). In contrast, Barclays maintained its 'Hold' rating on the company on July 29, reflecting a more cautious stance. The Procter & Gamble Company (NYSE:PG) offers branded consumer packaged goods globally, serving beauty, grooming, health care, fabric & home care, and baby, feminine & family care segments. It is included in our list of the Best Rebound Stocks To Buy. While we acknowledge the potential of PG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best AI Stocks to Buy Under $3 and Bill Ackman Stock Portfolio: Top 10 Stock Picks. Disclosure: None. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
15 hours ago
- Yahoo
Jim Cramer Says 'CME Has Lots of Options and Futures for Bitcoin and Ethereum'
CME Group Inc. (NASDAQ:CME) is one of the stocks Jim Cramer shed light on. Cramer discussed the positives around the company despite a downgrade by UBS in July, after the company posted its earnings. He remarked: 'CME Group, the parent of the Chicago Mercantile Exchange, the world's leading derivative marketplace, is a nearly $100 billion company you almost never hear about, right? It's up 18% year to date, down slightly from its June highs… CME Group generated 16% earnings growth. Veteran Chairman, CEO, Terry Duffy… told us, 'Demand for CME Group benchmark futures and options reached an all-time high in Q2 as clients around the globe turned to our markets to manage their business risk across asset classes.' Oh, and their average daily volume also rose 16%. These are record numbers… Stock market data on a laptop screen. Photo by Alesia Kozik on Pexels CME Group Inc. (NASDAQ:CME) operates global markets for trading futures and options across asset classes. The company also provides clearing, risk management, and market data services. While we acknowledge the potential of CME as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
17 hours ago
- Yahoo
Puerto Rico Investors Ask Appeals Court To Overturn UBS Lawsuit Dismissal
You can find original article here Wealthmanagement. Subscribe to our free daily Wealthmanagement newsletter. A Puerto Rico-based duo is asking a federal appeals court to overturn a lower court's dismissal of their lawsuit against UBS Financial Services. In the suit, Vanessa Santini Hernández and Lourdes González Gutiérrez argued the firm violated their conservative risk preferences by engaging in a 'scheme' to sell them risky bonds and securities. The duo filed the original suit in the Puerto Rico court last February. Santini is a doctor, while González is a 79-year-old San Juan retiree who previously worked in the mortgage banking industry. According to the complaint, they relied on UBS's counsel in investment matters, with the money invested representing their financial security. According to Santini, the firm understood her situation and desire for conservative investment objectives. In the complaint, the plaintiffs accused UBS of selling them Puerto Rico bonds and shares of closed-end mutual funds to boost their own profits, despite these products being excessively risky. According to the complaint, the plaintiffs were falsely told that the shares in the portfolio were PR Bonds guaranteed by the government. The plaintiffs alleged that UBS advisors 'explicitly' recommended the duo purchase the closed-end funds and bonds and continue holding the securities. 'The artificial market demand for the PR securities created by the selling scheme caused a surplus and excessive supply that far exceeded any market demand that made such investments much less worthy of credit or value and was an immediate cause of the hopeless fall of the PR bonds market and proximate cause of the breach of their contract with them and causing thus loss to the plaintiff,' the complaint read. According to the complaint, the plaintiffs didn't suffer financially until Puerto Rico's debt growth outpaced economic growth. In a July 2012 report from the New York Federal Reserve, it asserted that putting Puerto Rico on a path 'of robust, sustainable and inclusive growth remains a work in progress,' according to an analysis from the Journal for Corporate Finance. Within several years, credit agencies degraded several Puerto Rico bond issues to junk status, Puerto Rico defaulted on several bond commitments, and, according to NBC News, the government filed for the largest municipal bankruptcy in U.S. history in 2017. The government officially exited bankruptcy in 2022 with a massive public debt restructuring. On June 30, a Puerto Rico superior court agreed with a UBS motion to dismiss Santini and González's case. The court cited the length of time between the alleged wrongdoing and the case itself and claimed the suit lacked details on how UBS sought to deceive the investors. According to the judge, the complaint 'lacks particularized allegations as to what materially false or misleading misrepresentations or omissions were made by UBS, why those statements or omissions were false or misleading, when those statements or omissions were made, or who made the supposedly false or misleading misrepresentations or omissions.' Nevertheless, the plaintiffs notified the court that it was appealing the decision to the First Circuit Court of Appeals, whose jurisdiction includes Puerto Rico. UBS declined to comment, and an attorney for the plaintiffs didn't respond prior to publication.
